Inventor · disambiguated record
Ragab El-Rashidy
Also filed as: EL-RASHIDY RAGAB
22 granted patents·3 pending applications·1,229 citations·filing 1988–2014
97Inventor score
Files withPENTECH PHARMACEUTICALS INC19GENIX THERAPEUTICS GROUP LLC2EL-RASHIDY RAGAB1GYNEX INC1PHARMEDIC CO1
Top patents by PatentIndex Score
25 records- 0195US5624677AControlled release of drugs delivered by sublingual or buccal administrationPENTECH PHARMACEUTICALS INC·Filed 1995·Granted Apr 29, 1997·211 cites·20 claims
- 0292US6306437B1Apomorphine-containing dosage forms for ameliorating male erectile dysfunctionPENTECH PHARMACEUTICALS INC·Filed 2000·Granted Oct 23, 2001·34 cites·17 claims
- 0392US5770606ADosage forms and method for ameliorating male erectile dysfunctionPENTECH PHARMACEUTICALS INC·Filed 1995·Granted Jun 23, 1998·97 cites·21 claims
- 0491US5945117ATreatment of female sexual dysfunctionPENTECH PHARMACEUTICALS INC·Filed 1998·Granted Aug 31, 1999·84 cites·15 claims
- 0590US6566368B2Apomorphine-containing dosage form for ameliorating male erectile dysfunctionPENTECH PHARMACEUTICALS INC·Filed 2001·Granted May 20, 2003·32 cites·8 claims
- 0690US5939094ATransdermal administration of apomorphinePENTECH PHARMACEUTICALS INC·Filed 1996·Granted Aug 17, 1999·120 cites·13 claims
- 0789US6087362AApomorphine and sildenafil compositionPENTECH PHARMACEUTICALS INC·Filed 1999·Granted Jul 11, 2000·84 cites·20 claims
- 0888US5256652ATopical compositions and methods for treatment of male impotencePHARMEDIC CO·Filed 1990·Granted Oct 26, 1993·103 cites·21 claims
- 0983US6193992B1Female sexual dysfunction treatmentPENTECH PHARMACEUTICALS INC·Filed 1999·Granted Feb 27, 2001·45 cites·18 claims
- 1082US5562917ATransdermal administration of apomorphinePENTECH PHARMACEUTICALS INC·Filed 1994·Granted Oct 8, 1996·62 cites·3 claims
- 1181US5994363AAmelioration of apomorphine adverse effectsPENTECH PHARMACEUTICALS INC·Filed 1998·Granted Nov 30, 1999·51 cites·23 claims
- 1280US5888534AControlled release of drugs delivered by sublingual or buccal administrationPENTECH PHARMACEUTICALS INC·Filed 1997·Granted Mar 30, 1999·51 cites·22 claims
- 1379US6121276AApomorphine-containing dosage forms for ameliorating male erectile dysfunctionPENTECH PHARMACEUTICALS INC·Filed 1998·Granted Sep 19, 2000·43 cites·25 claims
- 1479US5672612AAmorphous paroxetine compositionPENTECH PHARMACEUTICALS INC·Filed 1996·Granted Sep 30, 1997·44 cites·11 claims
- 1570US6200983B1Dosage forms containing apomorphine for ameliorating male erectile dysfunctionPENTECH PHARMACEUTICALS INC·Filed 1999·Granted Mar 13, 2001·25 cites·3 claims
- 1665US5985889ADosage forms and method for ameliorating male erectile dysfunctionPENTECH PHARMACEUTICALS INC·Filed 1998·Granted Nov 16, 1999·20 cites·8 claims
- 1763US4889634ADialysate solution containing hydroxypropyl-beta-cyclodextrin and method of using sameGYNEX INC·Filed 1988·Granted Dec 26, 1989·87 cites·7 claims
- 1859US5830500ALow dose fluoxetine tabletPENTECH PHARMACEUTICALS INC·Filed 1996·Granted Nov 3, 1998·20 cites·8 claims
- 1955US6503927B1Amorphous paroxetine compositionPENTECH PHARMACEUTICALS INC·Filed 1999·Granted Jan 7, 2003·13 cites·21 claims
- 2055US2006217316A1Method for the treatment of prostate cancerEL-RASHIDY RAGAB·Filed 2004·Application pending·0 cites
- 2154US9408865B2Treatment of huntington'S diseaseGENIX THERAPEUTICS GROUP LLC·Filed 2014·Granted Aug 9, 2016·0 cites·5 claims
- 2250US2004092493A1Method for ameliorating male erectile dysfunctionFiled 2003·Application pending·0 cites
- 2349US8889125B2Treatment of Huntington's diseaseGENIX THERAPEUTICS GROUP LLC·Filed 2013·Granted Nov 18, 2014·0 cites·3 claims
- 2448US6638948B1Amorphous paroxetine compositionPENTECH PHARMACEUTICALS INC·Filed 1997·Granted Oct 28, 2003·3 cites·15 claims
- 2544US2002035131A1Regimen and kit for amelioration of premature ejaculationPENTECH PHARMACEUTICALS INC·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ragab El-Rashidy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →